Suppr超能文献

从放线菌中发现和合成无 leader 细菌素。

Discovery and synthesis of leaderless bacteriocins from the Actinomycetota.

机构信息

APC Microbiome Ireland, University College Cork, Cork, Ireland.

School of Microbiology, University College Cork, Cork, Ireland.

出版信息

J Bacteriol. 2024 Nov 21;206(11):e0029824. doi: 10.1128/jb.00298-24. Epub 2024 Oct 15.

Abstract

Leaderless bacteriocins are a unique class of bacteriocins that possess antimicrobial activity after translation and have few cases of documented resistance. Aureocin A53 and lacticin Q are considered two of the most well-studied leaderless bacteriocins. Here, we used genome mining to search for novel aureocin A53-like leaderless bacteriocins in GenBank and MGnify. We identified 757 core peptides across 430 genomes with 75 species found currently without characterized leaderless bacteriocin production. These include putative novel species containing bacteriocin gene clusters (BGCs) from the genera (sp. NBC_00237) and (sp. SL85). To date, all characterized leaderless bacteriocins have been found within the phylum Bacillota, but this study identified 97 core peptides within the phylum Actinomycetota. Members of this phylum are traditionally associated with the production of antibiotics, such is the case with the genus . Actinomycetota is an underexplored phylum in terms of bacteriocin production with no characterized leaderless bacteriocin production to date. The two novel leaderless bacteriocins arcanocin and arachnicin from Actinomycetota members sp. and sp., respectively, were chemically synthesized and antimicrobial activity was verified. These peptides were encoded in human gut (PRJNA485056) and oral (PRJEB43277) microbiomes, respectively. This research highlights the biosynthetic potential of Actinomycetota in terms of leaderless bacteriocin production and describes the first antimicrobial peptides encoded in the genera and .IMPORTANCEBacteriocins are gathering attention as alternatives to current antibiotics given the increasing incidence of antimicrobial resistance. Leaderless bacteriocins are considered a commercially attractive subclass of bacteriocins due to the ability to synthesize active peptide and low levels of documented resistance. Therefore, in this work, we mined publicly available data to determine how widespread and diverse leaderless bacteriocins are within the domain of bacteria. Actinomycetota, known for its antibiotic producers but lacking described and characterized bacteriocins, proved to be a rich source of leaderless bacteriocins-97 in total. Two such peptides, arcanocin and arachnicin, were chemically synthesized and have antimicrobial activity. These bacteriocins may provide a novel source of novel antimicrobials that could aid in the development of future alternative antimicrobials and highlight that the Actinomycetota are an underexplored resource of bacteriocin peptides.

摘要

无领导型细菌素是一类独特的细菌素,在翻译后具有抗菌活性,且有记录的耐药性病例很少。Aureocin A53 和乳链菌肽 Q 被认为是研究最充分的两种无领导型细菌素。在这里,我们使用基因组挖掘在 GenBank 和 MGnify 中搜索新型 Aureocin A53 样无领导型细菌素。我们在 430 个基因组中鉴定了 757 个核心肽,其中 75 个物种目前没有特征性的无领导型细菌素产生。其中包括来自属(NBC_00237 sp.)和属(SL85 sp.)的可能含有细菌素基因簇(BGC)的新型假定物种。迄今为止,所有特征性的无领导型细菌素都在厚壁菌门中发现,但本研究在放线菌门中鉴定了 97 个核心肽。该门的成员传统上与抗生素的产生有关,例如属。放线菌门在细菌素产生方面是一个尚未充分探索的门,迄今为止没有特征性的无领导型细菌素产生。分别来自放线菌门成员 sp. 和 sp. 的两种新型无领导型细菌素 arcanocin 和 arachnicin 已通过化学合成,并验证了其抗菌活性。这些肽分别编码在人类肠道(PRJNA485056)和口腔(PRJEB43277)微生物组中。这项研究突出了放线菌门在无领导型细菌素产生方面的生物合成潜力,并描述了属和属中编码的第一个抗菌肽。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8289/11580447/78aa2ebadbf5/jb.00298-24.f001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验